DEEPAK NITRITE — CAPACITY + CUSTOMER VALIDATION
- ₹1,400 Cr phenol/acetone project initially represented only a Stage 1 capex story.
- Before commissioning, customer outreach and seed marketing had already started showing encouraging demand.
- Indian phenol demand was also running stronger than originally assumed.
- Plant commissioned in November 2018.
- Utilisation crossed 80% within the first few months.
- FY20 operating cash flow subsequently reached ~₹765 Cr.
- Consolidated net debt/equity fell from 1.11x FY19 → 0.69x FY20 → 0.15x FY21.
- Key lesson: Demand validation + utilisation + debt reduction confirmed the capex-to-cash inflection.
VALIANT ORGANICS — APPROVAL-GATED CAPACITY INFLECTION
- Existing 4,800 MTPA chlorophenol plant was already operating near full utilisation.
- Expansion could increase capacity toward ~21,600 MTPA.
- Environmental approval was the major uncertainty.
- Existing utilisation had already validated demand.
- Balance sheet was virtually debt-free.
- Approval progress + capacity expansion + strong existing utilisation created the Stage 2 opportunity.
- Once approvals, commissioning and utilisation became obvious, much of the catalyst became priced in.
- Key lesson: Catalysts have an expiry date.
CG POWER — GOVERNANCE + BALANCE-SHEET INFLECTION
- CG Power had a viable industrial franchise trapped inside governance and balance-sheet problems.
- Tube Investments / Murugappa Group acquired control and infused fresh capital.
- Board and ownership changed.
- ~₹2,160 Cr debt claims were settled at ~₹1,000 Cr.
- Operational creditors and employee dues were addressed.
- Working-capital lines reopened.
- Customers had not disappeared; order book remained healthy.
- Credit rating moved from default to AA-.
- FY22 revenue subsequently reached ₹5,561 Cr, +88%, while PAT before exceptional items reached ₹405 Cr.
- Key lesson: In governance turnarounds, legal certainty comes first, liquidity second and earnings last.
TBZ — OWNERSHIP INFLECTION BUT OPERATING EVIDENCE STILL NEEDED
- GRT is acquiring control of TBZ, creating a potentially meaningful ownership change.
- GRT could bring procurement, inventory management, customer schemes and stronger retail execution.
- But operating evidence has not yet sufficiently confirmed the turnaround.
- Gold jewellery volumes declined from 3,424 kg FY23 to 2,249 kg FY26.
- FY26 operating cash flow was only ~₹30 Cr against PAT of ~₹202 Cr.
- Inventory and borrowings increased materially.
- Current setup is closer to Stage 1–1.5.
- Need volume growth, same-store growth, inventory improvement and cash-flow confirmation before calling it Stage 2.
ROYAL ENFIELD — DEMAND PULLED CAPACITY
- Demand exceeded supply before major capacity expansion.
- Long waiting periods demonstrated genuine product-market fit.
- Classic 350/500 and the new engine platform strengthened the product proposition.
- Management then invested to remove the production bottleneck.
- Oragadam plant started production in 2013 with 150,000-unit initial capacity.
- Motorcycle sales reached ~178,000 units in 2013 and production plans were raised further.
- Importantly, expansion was supported by a strong balance sheet rather than dangerous leverage.
- Key lesson: Demand pulling capacity into existence is much stronger than capacity searching for demand.
E2E NETWORKS — ASSET REGISTER BEFORE PROFIT EXPLOSION
- E2E was evolving from a generic cloud provider toward GPU infrastructure.
- GPU products appeared in the company's physical asset base and customer catalogue before becoming meaningful in reported profits.
- Computer equipment expanded significantly relative to the company's existing revenue base.
- Early capex was substantially supported by operating cash flow rather than excessive debt.
- The next critical evidence was utilisation and recurring customer revenue.
- Key lesson: Physical assets + product catalogue + customer commitments can reveal the next business before PAT does.
IEX — REGULATION BEFORE VOLUME
- IEX was already profitable; profitability itself was not the inflection.
- Regulatory changes increased the usefulness of exchange-based short-term electricity trading.
- Real-Time Market created additional opportunities for last-minute balancing.
- Existing network liquidity meant IEX could absorb the new market without massive incremental capital.
- Higher volumes therefore offered substantial operating leverage.
- Key lesson: Regulation can change the earnings trajectory before reported volumes reveal the full impact.
HOW TO DISTINGUISH A REAL INFLECTION FROM A TRAP
OPERATING CONFIRMATION
- Volumes growing faster than industry.
- Repeat orders / customer retention improving.
- Capacity utilisation crossing fixed-cost breakeven.
- Same-store sales / unit economics improving.
- New products becoming meaningful.
- Market share increasing without receivables exploding.
CASH FLOW / BALANCE-SHEET CONFIRMATION
- Receivable and inventory days remain stable or improve.
- Operating cash flow begins following EBITDA.
- Customer advances support the order book.
- Debt and interest burden decline.
- Expansion becomes increasingly self-funded.
- Incremental ROIC remains above cost of capital.
RED FLAG
- If reported P&L improves while cash conversion deteriorates materially, treat the claimed inflection with caution.
- Revenue growth financed by exploding receivables or inventory may not represent genuine improvement.
THE REPEATABLE PROCESS
- Identify what changed FIRST.
- Find at least 2 independent operating confirmations.
- Check what cash flow / balance sheet confirms.
- Understand what the P&L should show later.
- Define exactly what would invalidate the thesis.
- Finally, ask whether valuation still assumes the OLD earnings path.
THE IDEAL MULTIBAGGER SETUP
- Good underlying business.
- Leading indicators already improving.
- Two or more independent confirmations.
- Healthy cash flow / balance sheet.
- Earnings still look ordinary.
- Market expectations remain anchored to historical earnings.
- Clear runway for revenue + margin expansion.
- Valuation has NOT yet moved to Stage 4/5 expectations.
KEY TAKEAWAY
- The biggest asymmetry often sits at Stage 2: operating evidence is improving, cash/balance sheet confirms it, but earnings and market expectations have not yet caught up.
8September 5, 2026 1.7K 13
